Published in Cancer Res on September 01, 2007
Mitochondrial subversion in cancer. Cancer Prev Res (Phila) (2011) 1.54
Novel fusion transcripts associate with progressive prostate cancer. Am J Pathol (2014) 1.51
Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma. Blood (2013) 1.35
Molecular mechanisms by which selenoproteins affect cancer risk and progression. Biochim Biophys Acta (2009) 1.29
Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues. Prostate (2008) 1.14
Tumor suppressor function of the plasma glutathione peroxidase gpx3 in colitis-associated carcinoma. Cancer Res (2012) 1.13
p53-induced gene 3 mediates cell death induced by glutathione peroxidase 3. J Biol Chem (2012) 1.13
GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer. J Urol (2014) 1.12
DNA methylation changes in prostate cancer: current developments and future clinical implementation. Expert Rev Mol Diagn (2009) 1.08
Loss of glutathione peroxidase 3 expression is correlated with epigenetic mechanisms in endometrial adenocarcinoma. Cancer Cell Int (2010) 1.05
The Roles of Glutathione Peroxidases during Embryo Development. Front Mol Neurosci (2011) 1.03
Silencing of glutathione peroxidase 3 through DNA hypermethylation is associated with lymph node metastasis in gastric carcinomas. PLoS One (2012) 1.02
Reactive oxygen and nitrogen species induce protein and DNA modifications driving arthrofibrosis following total knee arthroplasty. Fibrogenesis Tissue Repair (2009) 1.01
Genome-wide methylation analysis of prostate tissues reveals global methylation patterns of prostate cancer. Am J Pathol (2013) 1.00
Clinical significance and therapeutic value of glutathione peroxidase 3 (GPx3) in hepatocellular carcinoma. Oncotarget (2014) 0.97
Regulation of prostate cancer cell invasion by modulation of extra- and intracellular redox balance. Free Radic Biol Med (2011) 0.96
Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression. J Ovarian Res (2011) 0.95
Genome-wide expression and copy number analysis identifies driver genes in gingivobuccal cancers. Genes Chromosomes Cancer (2011) 0.87
Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker. BMC Cancer (2010) 0.87
Identification of a DNA methylome profile of esophageal squamous cell carcinoma and potential plasma epigenetic biomarkers for early diagnosis. PLoS One (2014) 0.87
Gene expression profiling predicts a three-gene expression signature of endometrial adenocarcinoma in a rat model. Cancer Cell Int (2009) 0.87
Malignant fibrous histiocytoma--pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A pilot study. Langenbecks Arch Surg (2009) 0.87
Promoter hypermethylation and suppression of glutathione peroxidase 3 are associated with inflammatory breast carcinogenesis. Oxid Med Cell Longev (2014) 0.87
Differential response of normal (PrEC) and cancerous human prostate cells (PC-3) to phenethyl isothiocyanate-mediated changes in expression of antioxidant defense genes. Pharm Res (2010) 0.85
Variation in selenoenzyme genes and prostate cancer risk and survival. Prostate (2012) 0.85
Metallothionein 1 h tumour suppressor activity in prostate cancer is mediated by euchromatin methyltransferase 1. J Pathol (2013) 0.84
Identification of vitronectin as a novel serum marker for early breast cancer detection using a new proteomic approach. J Cancer Res Clin Oncol (2011) 0.84
Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent. Prostate (2012) 0.84
Is selenium a potential treatment for cancer metastasis? Nutrients (2013) 0.84
Selenium. Role of the essential metalloid in health. Met Ions Life Sci (2013) 0.82
High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate. Prostate (2011) 0.82
Niche-dependent gene expression profile of intratumoral heterogeneous ovarian cancer stem cell populations. PLoS One (2013) 0.81
GPX3 hypermethylation serves as an independent prognostic biomarker in non-M3 acute myeloid leukemia. Am J Cancer Res (2015) 0.80
Integrin α7 binds tissue inhibitor of metalloproteinase 3 to suppress growth of prostate cancer cells. Am J Pathol (2013) 0.80
Matrix metalloproteinase-19 promotes metastatic behavior in vitro and is associated with increased mortality in non-small cell lung cancer. Am J Respir Crit Care Med (2014) 0.80
A simple and reliable protocol for mouse serum proteome profiling studies by use of two-dimensional electrophoresis and MALDI TOF/TOF mass spectrometry. Proteome Sci (2008) 0.79
Diagnostic value of serum glutathione peroxidase 3 levels in patients with lung cancer. Thorac Cancer (2014) 0.79
Genomic Copy Number Variations in the Genomes of Leukocytes Predict Prostate Cancer Clinical Outcomes. PLoS One (2015) 0.78
MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice. Gastroenterology (2017) 0.78
Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma. Int J Mol Sci (2015) 0.78
GPX3 promoter is methylated in chronic myeloid leukemia. Int J Clin Exp Pathol (2015) 0.78
Human adipose-derived mesenchymal stromal cell pigment epithelium-derived factor cytotherapy modifies genetic and epigenetic profiles of prostate cancer cells. Cytotherapy (2014) 0.78
The role of mitochondria in the development and progression of lung cancer. Comput Struct Biotechnol J (2013) 0.78
BRCA1/2 mutations perturb telomere biology: characterization of structural and functional abnormalities in vitro and in vivo. Oncotarget (2016) 0.77
Prostate epithelium-specific deletion of the selenocysteine tRNA gene Trsp leads to early onset intraepithelial neoplasia. Am J Pathol (2014) 0.77
Down-regulation of GPX3 is associated with favorable/intermediate karyotypes in de novo acute myeloid leukemia. Int J Clin Exp Pathol (2015) 0.77
Oncogenic Activity of miR-650 in Prostate Cancer Is Mediated by Suppression of CSR1 Expression. Am J Pathol (2015) 0.77
Retracted GPX3 hypermethylation serves as an independent prognostic biomarker in non-M3 acute myeloid leukemia. Am J Cancer Res (2015) 0.77
Selenium-enriched foods are more effective at increasing glutathione peroxidase (GPx) activity compared with selenomethionine: a meta-analysis. Nutrients (2014) 0.76
One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling. Int J Mol Sci (2016) 0.75
Epigenetic and Glucocorticoid Receptor-Mediated Regulation of Glutathione Peroxidase 3 in Lung Cancer Cells. Mol Cells (2016) 0.75
The Clinical Significance and Potential Therapeutic Role of GPx3 in Tumor Recurrence after Liver Transplantation. Theranostics (2016) 0.75
GPX3 methylation in bone marrow predicts adverse prognosis and leukemia transformation in myelodysplastic syndrome. Cancer Med (2016) 0.75
The DNA replication licensing factor miniature chromosome maintenance 7 is essential for RNA splicing of epidermal growth factor receptor, c-Met, and platelet-derived growth factor receptor. J Biol Chem (2014) 0.75
Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis. Prostate (2016) 0.75
Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol (2004) 6.99
An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis. Science (2010) 6.47
Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer (2007) 3.57
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med (2015) 3.00
The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res (2003) 2.91
Gene expression analysis of prostate cancers. Mol Carcinog (2002) 2.51
Lack of Fas antagonism by Met in human fatty liver disease. Nat Med (2007) 2.48
Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes. Cancer Res (2002) 2.05
Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors. BMC Cancer (2005) 1.87
A mechanism of cell survival: sequestration of Fas by the HGF receptor Met. Mol Cell (2002) 1.82
Beta-catenin is temporally regulated during normal liver development. Gastroenterology (2004) 1.69
Oxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosis. J Biol Chem (2008) 1.69
Using the epigenetic field defect to detect prostate cancer in biopsy negative patients. J Urol (2012) 1.60
Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver. Gastroenterology (2005) 1.58
Tubular epithelial cell dedifferentiation is driven by the helix-loop-helix transcriptional inhibitor Id1. J Am Soc Nephrol (2007) 1.56
Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinase. Hepatology (2009) 1.54
Novel fusion transcripts associate with progressive prostate cancer. Am J Pathol (2014) 1.51
HER2 gene amplification and chromosome 17 copy number do not predict survival of patients with resected pancreatic adenocarcinoma. Dig Dis Sci (2008) 1.45
Global methylation patterns in idiopathic pulmonary fibrosis. PLoS One (2012) 1.44
Multiple ovarian transplants to rescue a transgenic line of mice. Lab Anim (NY) (2010) 1.43
Myopodin-mediated suppression of prostate cancer cell migration involves interaction with zyxin. Cancer Res (2006) 1.41
A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas. Am J Surg Pathol (2010) 1.39
DOG1: a novel marker of salivary acinar and intercalated duct differentiation. Mod Pathol (2012) 1.34
Significance of EGFR protein expression and gene amplification in non-small cell lung carcinoma. Am J Clin Pathol (2006) 1.34
Hierarchical modularity of nested bow-ties in metabolic networks. BMC Bioinformatics (2006) 1.33
Liver-specific ablation of integrin-linked kinase in mice results in abnormal histology, enhanced cell proliferation, and hepatomegaly. Hepatology (2008) 1.31
Profibrotic role of miR-154 in pulmonary fibrosis. Am J Respir Cell Mol Biol (2012) 1.30
Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis. Am J Pathol (2011) 1.27
Modular co-evolution of metabolic networks. BMC Bioinformatics (2007) 1.23
Analysis of integrin alpha7 mutations in prostate cancer, liver cancer, glioblastoma multiforme, and leiomyosarcoma. J Natl Cancer Inst (2007) 1.22
Cell cycle effects resulting from inhibition of hepatocyte growth factor and its receptor c-Met in regenerating rat livers by RNA interference. Hepatology (2007) 1.20
A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases. Hum Pathol (2009) 1.15
Calpain-2 as a target for limiting prostate cancer invasion. Cancer Res (2003) 1.14
p53-induced gene 3 mediates cell death induced by glutathione peroxidase 3. J Biol Chem (2012) 1.13
CSR1 suppresses tumor growth and metastasis of prostate cancer. Am J Pathol (2006) 1.13
Tumor epidermal growth factor receptor and EGFR PY1068 are independent prognostic indicators for head and neck squamous cell carcinoma. Clin Cancer Res (2012) 1.12
Progressive genetic alterations of adenoid cystic carcinoma with high-grade transformation. Arch Pathol Lab Med (2011) 1.11
Expression of myopodin induces suppression of tumor growth and metastasis. Am J Pathol (2004) 1.10
Gene deletions and amplifications in human hepatocellular carcinomas: correlation with hepatocyte growth regulation. Am J Pathol (2012) 1.10
PI3K is negatively regulated by PIK3IP1, a novel p110 interacting protein. Biochem Biophys Res Commun (2007) 1.09
RNA interference against hepatic epidermal growth factor receptor has suppressive effects on liver regeneration in rats. Am J Pathol (2010) 1.05
Suppression of liver regeneration and hepatocyte proliferation in hepatocyte-targeted glypican 3 transgenic mice. Hepatology (2010) 1.04
Genome abnormalities precede prostate cancer and predict clinical relapse. Am J Pathol (2012) 1.03
Involvement of 85-kd cytosolic phospholipase A(2) and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells. Hepatology (2002) 1.02
Genome-wide methylation analysis of prostate tissues reveals global methylation patterns of prostate cancer. Am J Pathol (2013) 1.00
Somatic mutation and functional polymorphism of a novel regulatory element in the HGF gene promoter causes its aberrant expression in human breast cancer. J Clin Invest (2009) 0.99
Preexisting epithelial diversity in normal human livers: a tissue-tethered cytometric analysis in portal/periportal epithelial cells. Hepatology (2013) 0.99
Paradoxical relationship between the degree of EGFR amplification and outcome in glioblastomas. Am J Surg Pathol (2012) 0.98
Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation. Am J Pathol (2009) 0.97
A hepatocyte growth factor receptor (Met)-insulin receptor hybrid governs hepatic glucose metabolism. Nat Med (2011) 0.97
Mouse fetal liver cells in artificial capillary beds in three-dimensional four-compartment bioreactors. Am J Pathol (2005) 0.97
High throughput screening of methylation status of genes in prostate cancer using an oligonucleotide methylation array. Carcinogenesis (2004) 0.96
A functional polymorphism at the transcriptional initiation site in beta2-glycoprotein I (apolipoprotein H) associated with reduced gene expression and lower plasma levels of beta2-glycoprotein I. Eur J Biochem (2003) 0.96
MCM7 interacts with androgen receptor. Am J Pathol (2008) 0.96
Network analysis of temporal effects of intermittent and sustained hypoxia on rat lungs. Physiol Genomics (2008) 0.96
Gene expression analysis of human soft tissue leiomyosarcomas. Hum Pathol (2003) 0.95
Let-7d microRNA affects mesenchymal phenotypic properties of lung fibroblasts. Am J Physiol Lung Cell Mol Physiol (2014) 0.95
EGFR fluorescence in situ hybridization-positive lung adenocarcinoma: incidence of coexisting KRAS and BRAF mutations. Hum Pathol (2010) 0.94
Hepatocyte growth factor protects against hypoxia/reoxygenation-induced apoptosis in endothelial cells. J Biol Chem (2003) 0.94
Interaction of integrin-linked kinase and miniature chromosome maintenance 7-mediating integrin {alpha}7 induced cell growth suppression. Cancer Res (2010) 0.93
Whole-genome methylation sequencing reveals distinct impact of differential methylations on gene transcription in prostate cancer. Am J Pathol (2013) 0.93
Liver-specific ablation of integrin-linked kinase in mice results in enhanced and prolonged cell proliferation and hepatomegaly after phenobarbital administration. Toxicol Sci (2009) 0.92
Cytokine-like factor 1 gene expression is enriched in idiopathic pulmonary fibrosis and drives the accumulation of CD4+ T cells in murine lungs: evidence for an antifibrotic role in bleomycin injury. Am J Pathol (2012) 0.92
Fluorescence in situ hybridization for detection of MAML2 rearrangements in oncocytic mucoepidermoid carcinomas: utility as a diagnostic test. Hum Pathol (2011) 0.92
Inactivation of myopodin expression associated with prostate cancer relapse. Urology (2006) 0.92
Vertebral fractures and the misclassification of osteoporosis in men with prostate cancer. J Clin Densitom (2011) 0.92
The importance of 10q status in an outcomes-based comparison between 1p/19q fluorescence in situ hybridization and polymerase chain reaction-based microsatellite loss of heterozygosity analysis of oligodendrogliomas. J Neuropathol Exp Neurol (2012) 0.92
Acyl-CoA synthetase 1 is induced by Gram-negative bacteria and lipopolysaccharide and is required for phospholipid turnover in stimulated macrophages. J Biol Chem (2013) 0.91
Scaffolds containing growth factors and extracellular matrix induce hepatocyte proliferation and cell migration in normal and regenerating rat liver. J Hepatol (2010) 0.90
Feature-based interpolation of diffusion tensor fields and application to human cardiac DT-MRI. Med Image Anal (2011) 0.90
Protein expression and gene amplification of epidermal growth factor receptor in thymomas. Cancer (2005) 0.88
HER2 amplification in gastroesophageal adenocarcinoma: correlation of two antibodies using gastric cancer scoring criteria, H score, and digital image analysis with fluorescence in situ hybridization. Am J Clin Pathol (2012) 0.88
Bioinformatics analysis of metastasis-related proteins in hepatocellular carcinoma. World J Gastroenterol (2008) 0.87
Characterization of high-grade ductal carcinoma in situ with and without regressive changes: diagnostic and biologic implications. Appl Immunohistochem Mol Morphol (2009) 0.87
p63 expression in assessment of bronchioloalveolar proliferations of the lung. Mod Pathol (2004) 0.86
The prognostic value of Ki-67, p53, epidermal growth factor receptor, 1p36, 9p21, 10q23, and 17p13 in skull base chordomas. Arch Pathol Lab Med (2010) 0.86
Promotion of Fas-mediated apoptosis in Type II cells by high doses of hepatocyte growth factor bypasses the mitochondrial requirement. J Cell Physiol (2007) 0.85